78. Naito H., Ikeda A., Hasegawa K., et al. (1999). Characterization of human serum mannanbinding protein promoter. The Journal of Biochemistry. 126(6):10041012.
79. Bernig T., Breunis W., Brouwer N., et al. (2005). An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3′ haplotypes could modify circulating levels of mannosebinding lectin. Human genetics. 118(34):404415.
80. Seyfarth J., Garred P., Madsen H.O. (2005). The ‘involution’of mannose binding lectin. Human Molecular Genetics. 14(19):28592869.
81. Falzacappa M.V., Segat L., Puppini B., et al. (2004). Evolution of the mannosebinding lectin gene in primates. Genes & Immunity. 5(8):653 661.
82. Endo Y., Liu Y., Fujita T. Structure and function of ficolins. Current Topics in Complement: Springer; 2006. p. 265279.
83. Ohashi T., Erickson H.P. (2004). The disulfide bonding pattern in ficolin multimers. Journal of Biological Chemistry. 279(8):65346539.
84. Matsushita M., Endo Y., Taira S., et al. (1996). A novel human serum lectin with collagenand fibrinogenlike domains that functions as an opsonin. Journal of Biological Chemistry. 271(5):24482454.
85. Doolittle R.F. (1992). A detailed consideration of a principal domain of vertebrate fibrinogen and its relatives. Protein Science. 1(12):15631577.
86. Lynch N.J., Roscher S., Hartung T., et al. (2004). Lficolin specifically binds to lipoteichoic acid, a cell wall constituent of Grampositive bacteria, and activates the lectin pathway of complement. The Journal of Immunology. 172(2):11981202.
87. Nahid A.M., Sugii S. (2006). Binding of porcine ficolinα to
Có thể bạn quan tâm!
-
Mối Liên Quan Giữa Nồng Độprotein Mbl Với Mức Độ Bệnh Và Một Số Biểu Hiện Lâm Sàng, Cận Lâm Sàng Trong Bệnh Sốt Xuất Huyết Dengue -
Về Mối Liên Quan Giữa Tính Đa Hình Gen Fcn2 Và Nồng Độ Protein Ficolin2 Ở Bệnh Sốt Xuất Huyết Dengue -
Văn Đình Hoa, Nguyễn Ngọc Lanh (2006). Sinh Lý Bệnh Và Miễn Dịch. -
Nghiên cứu tính đa hình gen MBL2, FCN2 và nồng độ protein MBL, Ficolin-2 ở bệnh nhân sốt xuất huyết Dengue - 23
Xem toàn bộ 189 trang tài liệu này.
lipopolysaccharides from Gramnegative bacteria and lipoteichoic acids from Grampositive bacteria. Developmental & Comparative Immunology. 30(3):335343.
88. Krarup A., Thiel S., Hansen A., et al. (2004). Lficolin is a pattern recognition molecule specific for acetyl groups. Journal of Biological Chemistry. 279(46):4751347519.
89. Matsushita M., Kuraya M., Hamasaki N., et al. (2002). Activation of the lectin complement pathway by Hficolin (Hakata antigen). The Journal of Immunology. 168(7):35023506.
90. Endo Y., Nonaka M., Saiga H., et al. (2003). Origin of mannosebinding lectinassociated serine protease (MASP)1 and MASP3 involved in the lectin complement pathway traced back to the invertebrate, amphioxus. The Journal of Immunology. 170(9):47014707.
91. Kuraya M., Ming Z., Liu X., et al. (2005). Specific binding of Lficolin and Hficolin to apoptotic cells leads to complement activation. Immunobiology. 209(9):689697.
92. Hummelshøj T., MuntheFog L., Madsen H.O., et al. (2008). Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns. Molecular Immunology. 45(9):25082520.
93. Bidula S., Sexton D.W., Schelenz S. (2019). Ficolins and the recognition of pathogenic microorganisms: an overview of the innate immune response and contribution of single nucleotide polymorphisms. Journal of Immunology Research.
94. Hummelshoj T., MuntheFog L., Madsen H.O., et al. (2005). Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin2. Human molecular genetics. 14(12):16511658.
95. Munthe‐Fog L., Hummelshøj T., Hansen B., et al. (2007). The impact of FCN2 polymorphisms and haplotypes on the Ficolin‐2 serum levels. Scandinavian journal of immunology. 65(4):383392.
96. Cedzynski M., Nuytinck L., Atkinson A., et al. (2007). Extremes of L‐ ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene. Clinical & Experimental Immunology. 150(1):99104.
97. Garred P., Honoré C., Ma Y.J., et al. (2009). MBL2, FCN1, FCN2 and
FCN3—the genes behind the initiation of the lectin pathway of complement. Molecular immunology. 46(14):27372744.
98. Le Y., Tan S., Lee S., et al. (1997). Purification and binding properties of a human ficolinlike protein. Journal of Immunological Methods. 204(1):4349.
99. Chapman S.J., Vannberg F.O., Khor C.C., et al. (2007). Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease. Molecular Immunology. 44(12):32673270.
100. Ruskamp J.M., Hoekstra M.O., Postma D.S., et al. (2009). Exploring the role of polymorphisms in ficolin genes in respiratory tract infections in children. Clinical & Experimental Immunology. 155(3):433440.
101. MessiasReason I., Kremsner P.G., Kun J.F. (2009). Functional haplotypes that produce normal ficolin2 levels protect against clinical leprosy. The Journal of Infectious Diseases.801804.
102. Avirutnan P., Hauhart R.E., Marovich M.A., et al. (2011). Complement mediated neutralization of dengue virus requires mannosebinding lectin. mBio. 2(6).
103. Shresta S. (2012). Role of complement in dengue virus infection: protection or pathogenesis? mBio. 3(1).
104. Figueiredo G.G., Cezar R.D., Freire N.M., et al. (2016). Mannose binding lectin gene (MBL2) polymorphisms related to the mannose binding lectin low levels are associated to dengue disease severity. Human Immunology. 77(7):571575.
105. Bộ
Y tế. (2011). Hướng dẫn chẩn đoán, điều trị
Dengue. 458/QĐBYT.
106. Đỗ
Trung Phấn (2006). Các chỉ số
huyết học người Việt Nam giai
đoạn 1995 2000,
Nội.
Huyết học truyền máu, Nhà xuất bản Y học, Hà
107. Nguyễn Thế Khanh và Phạm Tử Dương (2005). Xét Nghiệm Sử Dụng Trong Lâm Sàng, Nhà xuất bản Y học, Hà Nội.
108. Tong H. V., Antony J.S., Ojurongbe O., et al. (2013). Mannosebinding lectin and susceptibility to schistosomiasis. The Journal of infectious diseases. 207(11):16751683.
109. Parkash O., Almas A., Jafri S.W., et al. (2010). Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia). BMC Gastroenterology. 10(1):18.
110. Trịnh Công Điển (2017). Nghiên cứu mối liên quan giữa týp vi rút với một số đặc điểm lâm sàng, cận lâm sàng ở bệnh nhân sốt xuất huyết Dengue Học viện Quân y, Luận văn thạc sĩ Y học, Học viện Quân Y.
111. Kassim F.M., Izati M.N., TgRogayah T., et al. (2011). Use of dengue NS1 antigen for early diagnosis of dengue virus infection. Southeast Asian J Trop Med Public Health. 42(3):562569.
112. Diệp Thanh Hải, Đỗ Kiến Quốc, Nguyễn Thanh Vũ và cộng sự
(2013). Đặc điểm dịch tễ học bệnh sốt xuất huyết Dengue dựa vào hệ
thống giám sát trọng điểm ở huyện Mang Thít, tỉnh Vĩnh Long năm
20122013. Tạp chí Y học Dự phòng. 146(10):106111.
113. Pant S., Goel A., Gangwar P.K., et al. (2019). Genetic association of MBL2 gene polymorphisms with filarial chyluria. Bioinformation. 15(11):806.
114. Singh H., Jadhav S., Chauware V. (2021). Impact of MBL2 coding region polymorphism on modulation of HAND and HIV1 acquisition. Microbial Pathogenesis. 160:105163.
115. Mwesigwa S., Moulds J.M., Chen A., et al. (2018). Whole‐exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition. Transfusion. 58(3):726735.
116. Pehlivan S., Köse M., Mese S., et al. (2021). Investigation of MBL2 and
NOS3 functional gene variants in suspected COVID19 PCR (–) patients.
Pathogens and Global Health.17.
117. Sena M.A., da Silva Castanha P.M., Guimarães A.B.G., et al. (2022). Mannosebinding lectin levels and MBL2 gene polymorphisms are associated to dengue infection in Brazilian children at the early ages. International Journal of Infectious Diseases.
118. Kalia N., Singh J., Sharma S., et al. (2019). SNPs in 3′UTR region of MBL2 increases susceptibility to recurrent vulvovaginal infections by altering sMBL levels. Immunobiology. 224(1):4249.
119. Alves Pedroso M., Boldt A., Pereira‐Ferrari L., et al. (2008). Mannan‐ binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy. Clinical & Experimental Immunology. 152(2):258264.
120. Goeldner I., Skare T.L., Utiyama S.R., et al. (2014). Mannose binding lectin and susceptibility to rheumatoid arthritis in Brazilian patients and their relatives. PLoS One. 9(4):e95519.
121. Liu C., He T., Rong Y., et al. (2016). Association of mannosebinding lectin polymorphisms with tuberculosis susceptibility among Chinese. Scientific Reports. 6(1):16.
122. Mishra A., Antony J.S., Sundaravadivel P., et al. (2015). Association of ficolin2 serum levels and FCN2 genetic variants with Indian visceral leishmaniasis. PloS one. 10(5):e0125940.
123. Faik I., Oyedeji S.I., Idris Z., et al. (2011). Ficolin2 levels and genetic polymorphisms of FCN2 in malaria. Human Immunology. 72(1):7479.
124. Osthoff M., Jaeger V.K., Heijnen I.A., et al. (2019). Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a crosssectional study. Arthritis Research & Therapy. 21(1):18.
125. Tereshchenko S.Y., Smolnikova M.V., Zobova S. (2020). Complement activation lectin pathway (mannosebinding lectin and ficolin) genes polymorphism as the risk factor of CagA positive chronic Helicobacter pylori infection in adolescents. Russian Journal of Infection and Immunity. 10(1):180186.
126. Ashmawy I., ElLebedy D., Awadallah E., et al. (2020). Association of FCN2 gene rs3124954 and STAT4 gene rs7582694 polymorphisms with juvenile onset systemic lupus erythematosus and lupus nephritis in a sample of Egyptian children. Gene Reports. 21:100968.
127. Ambrosio A.R., Bavia L., Hiraiwa P.M., et al. (2021). The lectin pathway of complement and the initial recognition of Leishmania infantum promastigotes. Life Sciences. 282:119793.
128. Elkoumi M., Emam A., Allah M., et al. (2019). Association of ficolin2 gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multicenter study. Lupus. 28(8):9951002.
129. Kempen G., Meijvis S., Endeman H., et al. (2017). Mannose‐binding lectin and l‐ficolin polymorphisms in patients with community‐acquired
pneumonia caused by intracellular pathogens. Immunology. 151(1):81 88.
130. BąkRomaniszyn L., Świerzko A.S., Sokołowska A., et al. (2020).
Mannosebinding lectin (MBL) in adult patients with inflammatory bowel disease. Immunobiology. 225(1):151859.
131. Gomaa M.H., Ali S.S., Fattouh A.M., et al. (2018). MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study. Pediatric Rheumatology. 16(1):24.
132. Graudal N.A., Madsen H.O., Tarp U., et al. (2000). The association of variant mannose‐binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 43(3):515521.
133. Mullighan C.G., Heatley S., Doherty K., et al. (2002). Mannosebinding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood, The Journal of the American Society of Hematology. 99(10):35243529.
134. Ornelas A.M., XavierdeCarvalho C., AlvaradoArnez L.E., et al. (2019). Association between MBL2 haplotypes and dengue severity in children from Rio de Janeiro, Brazil. Memórias do Instituto Oswaldo Cruz. 114.
135. Prommalikit O. (2015). Association between mannosebinding lectin gene polymorphisms and susceptibility to dengue virus infection: a preliminary report. Infectious Disease Association of Thailand. 46:29.
136. Ouf E.A., Ojurongbe O., Akindele A.A., et al. (2012). Ficolin2 levels and FCN2 genetic polymorphisms as a susceptibility factor in schistosomiasis. The Journal of Infectious Diseases. 206(4):562570.
137. Świerzko A.S., Jarych D., Gajek G., et al. (2021). Polymorphisms of the
FCN2 Gene 3’UTR Region and Their Clinical Associations in Preterm Newborns. Frontiers in Immunology. 12.
138. Khor C.C., Chau T.N.B., Pang J., et al. (2011). Genomewide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nature Genetics. 43(11):1139.
139. Elshamaa M.F., Hamza H., Abd El Rahman N., et al. (2018). Association of ficolin2 (FCN2) functional polymorphisms and protein levels with rheumatic fever and rheumatic heart disease: relationship with cardiac function. Archives of Medical Sciences Atherosclerotic Diseases. 3:e142.
140. Erkan A.N., Oz I., Terzi Y.K., et al. (2016). FCN2 c. 772G> T polymorphism is associated with chronic adenoiditis and/or tonsillitis, but not− 4 A> G and− 602 G> A. International Journal of Pediatric Otorhinolaryngology. 87:14.
141. Marzetti V., Di Battista C., Ferrante R., et al., editors (2017). MBL2 and FCN2 gene polymorphisms in a cohort of Italian children with rheumatic fever: A case–control study. Seminars in arthritis and rheumatism: Elsevier.
142. DabrowskaZamojcin E., Czerewaty M., Malinowski D., et al. (2018). Ficolin2 gene rs7851696 polymorphism is associated with delayed graft function and acute rejection in kidney allograft recipients. Archivum Immunologiae et Therapiae Experimentalis. 66(1):6572.
143. Holdaway J., Deacock S., Williams P., et al. (2016). Mannosebinding lectin deficiency and predisposition to recurrent infection in adults. Journal of Clinical Pathology. 69(8):731736.
144. Darmawan A.B., Soesatyo M.H., Restuti R.D., et al. (2018). The role of mannosebinding lectin serum level in tubotympanic chronic suppurative otitis media. International Journal of Otolaryngology. 2018.
145. Heng Y., Cong Y., Liang Y., et al. (2018). Association study between mannosebinding lectin (MBL) polymorphisms and serum MBL protein levels after Mycoplasma ovipneumoniae infection in sheep. 24(1).
146. Tereshchenko S., Smolnikova M., Gorbacheva N., et al (2019). MannoseBinding Lectin Plasma Concentration and MBL Gene Rs1800450 Polymorphism in Asthmatics Children. American Thoracic Society. p. A1289A1289.
147. Badarukhiya J.A., Tupperwar N., Nizamuddin S., et al. (2021). Novel FCN2 Variants and Haplotypes are Associated with Rheumatic Heart Disease. DNA and Cell Biology. 40(10):13381348.
148. Chen T., Hu Y., Ding Q., et al. (2015). Serum ficolin2 concentrations are significantly changed in patients with hepatitis B virus infection and liver diseases. Virologica Sinica. 30(4):249260.
149. Luo F., Chen T., Liu J., et al. (2016). Ficolin2 binds to HIV1 gp120 and blocks viral infection. Virologica Sinica. 31(5):406414.
150. Carbone F., Valente A., Perego C., et al. (2021). Ficolin2 serum levels predict the occurrence of acute coronary syndrome in patients with severe carotid artery stenosis. Pharmacological Research. 166:105462.
151. Colliard S., Jourde‐Chiche N., Clavarino G., et al. (2018). Autoantibodies targeting ficolin‐2 in systemic lupus erythematosus patients with active nephritis. Arthritis Care & Research. 70(8):1263 1268.
152. Jalal P.J., King B.J., Saeed A., et al. (2019). Elevated serum activity of MBL and ficolin2 as biomarkers for progression to hepatocellular carcinoma in chronic HCV infection. Virology. 530:99106.
153. Giraudi P.J., Salvoza N., Bonazza D., et al. (2022). Ficolin2 Plasma Levels Assesses Liver Fibrosis in NonAlcoholic Fatty Liver Disease.
154. Carr J.M., Cabezas‐Falcon S., Dubowsky J.G., et al. (2020). Dengue virus and the complement alternative pathway. FEBS Letters. 594(16):25432555.
155. CabezasFalcon S., Norbury A.J., HulmeJones J., et al. (2021). Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouse. Journal of General Virology.001547.
156. Liu J., Ali M.A., Shi Y., et al. (2009). Specifically binding of Lficolin to Nglycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cellular &Molecular Immunology. 6(4):235244.
157. Hamed M.R., Brown R.J., Zothner C., et al. (2014). Recombinant human Lficolin directly neutralizes hepatitis C virus entry. Journal of Innate Immunity. 6(5):676684.
158. Rantala A., Lajunen T., Juvonen R., et al. (2008). Mannosebinding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. Journal of Infectious Diseases. 198(8):12471253.